Toolkit organiseren activiteit voor sportaanbieders (PDF)

Publicaties
dr. B.C. Tanis
Aaldriks AA, van der Geest LG, Giltay EJ, le Cessie S, Portielje JE, Tanis BC,
Nortier JW, Maartense E. Frailty and malnutrition predictive of mortality risk in older
patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol.
2013;4:218-226.
Van der Geest LGM, Portielje JEA, Weijl NI, Tanis BC, Tollenaar RAEWM,
Struikmans H, Nortier JW. Complicated postoperative recovery increases omission,
delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon
cancer. Colorectal Dis. 2013;15:582-591.
Aaldriks AA, Maartense E, Giltay EJ, le Cessie S, van der Geest KGM, Portielje J,
Tanis BC, Nortier JWR. Prognostic value of geriatric assessment in older breast
cancer patients with advanced breast cancer receiving chemotherapy. Breast.
2013;22:753-60.
Nossent AY, Eikenboom JC, Tanis BC, Doggen CJ, Rosendaal FR. Haplotypes
encoding the factor VIII 1214 Glu variation and the risk of myocardial infarction. J
Thromb Haemost. 2007;5:619-621.
Tanis BC, Algra A, van der Graaf Y, Helmerhorst FM, Rosendaal FR. Procoagulant
factors and the risk of myocardial infarction in young women. Eur J Haematol.
2006;77:67-73.
Giordano PC, Plancke A, van Meir CA, Janssen CA, Kok PJ, van Rooijen- Nijdam
IH, Tanis BC, van Huisseling JC, Versteegh FG. Carrier diagnostics and prevention
of hemoglobinopathies in early pregnancy in the Netherlands: a pilot study. Prenat
Diagn. 2006;26:718-724.
Nossent AY, Eikenboom JC, Vos HL, Bakker E, Tanis BC, Doggen CJ, Bertina RM,
Rosendaal FR. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII
levels and the risk of venous thrombosis. Thromb Haemost. 2006;95:942-948.
Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A.
Erfelijke stollingsstoornissen, oral anticonceptiva en het risico op een hartinfarct.
Hart Bulletin. 2006;37:30-33.
Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A.
Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J
Thromb Haemost. 2005;3:1213-1217.
Groene Hart Ziekenhuis l Laatst afgedrukt op: 18-2-2014/3:06 PM
1/4
Ball LM, Silvius AM, Tanis BC, Bredius RM, Egeler RM, Fibbe WE, Brand A.
Granulocytentransfusies bij neutropene patienten met levensbedreigende infecties.
Nederlands Tijdschrift voor Hematologie. 2005;2:42-49.
Tanis BC, Kapiteijn KC, Hage RM, Rosendaal FR, Helmerhorst FM. Dutch women
with a low birth weight have an increased risk of myocardial infarction later in life: a
case control study. Reprod Health. 2005;10;2:1.
Tanis BC, Blom HJ, Bloemenkamp DG, van den Bosch MA, Algra A, van der Graaf
Y, Rosendaal FR. Folate, homocysteine levels, methylenetetrahydrofolatereductase
(MTHFR) 677C T variant, and the risk of myocardial infarction in young women:
effect of female hormones on homocysteine levels. J Thromb Haemost. 2004,1:3540.
Van den Bosch MA, Bloemenkamp DG, Mali WP, Kemmeren JM, Tanis BC, Algra A,
Rosendaal FR, van der Graaf Y. Hyperhomocysteinemia and the risk of peripheral
arterial occlusive disease in young women. J Vasc Surgery. 2003;38:772-778.
Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van der
Graaf Y, Rosendaal FR. Prothrombotic coagulation defects and cardiovascular risk
factors in young women with myocardial infarction. Br J Haematol. 2003;122:471478.
Rosendaal FR, van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens,
progestagens and thrombosis. J Thromb Haemost. 2003;2:1-10.
Tanis BC. Oral contraceptives and the risk of myocardial infarction. Eur Heart J.
2003;24:377-380.
Bloemenkamp DG, Mali WP, Tanis BC, van den Bosch MA, Kemmeren JM, Algra A,
van der Graaf Y. Functional health and well-being of relatively young women with
peripheral arterial disease is decreased but stable after diagnosis. J Vasc Surgery.
2003;38:104-110.
Tanis BC, Rosendaal FR. Venous and arterial thrombosis during oral contraceptive
use: risks and risk factors. Sem in Vasc Medicine. 2003;3:69-84.
Van den Bosch MA, Kemmeren JM, Tanis BC, Helmerhorst FM, Manger Cats V,
Algra A, van der Graaf Y. The RATIO study: oral contraceptives and the risk of
peripheral arterial disease in young women. J Thromb Haemost. 2003;1:439-444.
Bloemenkamp DG, van den Bosch MA, Mali WP, Tanis BC, Rosendaal FR,
Kemmeren JM, Algra A, Visseren FL, van der Graaf Y. Novel risk factors for
peripheral arterial disease in young women. Am J Med. 2002;113:462-467.
Groene Hart Ziekenhuis l Laatst afgedrukt op: 18-2-2014/3:06 PM
2/4
Van den Bosch MA, Mali WP, Bloemenkamp DG, Kemmeren JM, Tanis BC, Algra A,
Rosendaal FR, van der Graaf Y. Increased pregnancy loss in young women with
aortoiliac disease. Atherosclerosis. 2002;164:121-127.
Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, van den Bosch MA,
Kemmeren JM, Algra A, Visseren FL, van der Graaf Y. The relation between
Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine
concentration. Eur J Clin. Invest. 2002;32:549-555.
Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, van den Bosch MA,
Kemmeren JM, Algra A, Ossewaarde JM, Visseren FL, van Loon AM, van der Graaf
Y. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and
the risk of peripheral arterial disease in young women. Atherosclerosis.
2002;163:149-156.
Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der
Graaf Y, Rosendaal FR, Algra A. Risk of Arterial Thrombosis in Relation to Oral
Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke.
Stroke. 2002;33:1202-1208.
Tanis BC, van den Bosch MA, Kemmeren JM, Manger Cats V, Helmerhorst FM,
Algra A, van der Graaf Y, Rosendaal FR. Oral Contraceptives and the Risk of
Myocardial Infarction. N Engl J Med. 2001;345:1787-1793.
Van den Bosch MA, Tanis BC, Kemmeren JM. Roaming through methodology.
XVIII. Selection of control groups. Ned Tijdschr v Geneesk. 2000;144:797-800.
Tanis BC, van der Meer FJ, Bloem RM, Vlasveld LT. Successful excision of a
pseudotumour in a congenitally factor V deficient patient. Br J Haematol.
1998;100:380-382.
Witte EH, Tanis BC, van Hall EV. Medische aspecten van zwangerschap tijdens de
opleiding tot specialist. Medisch Contact. 1997;52:911-912.
Vermorken JB, Guastalla JP, Hatty SR, Seitz DE, Tanis BC, McDaniels C, Clavel
MD. Phase I study of gemcitabine using a once every 2 weeks schedule. Br J
Cancer. 1997;76:1489-1493.
Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on
hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of
intervention studies. Clin Endocrinol. 1996;44:643-649.
Tanis BC, Verburgh CA, van der Pijl JW, van 't Wout JW. Aspergillus peritonitis in
peritoneal dialysis. Nephrol Dial Transplant. 1996;11:752.
Groene Hart Ziekenhuis l Laatst afgedrukt op: 18-2-2014/3:06 PM
3/4
Tanis BC, Verburgh CA, van 't Wout JW, van der Pijl JW. Aspergillus peritonitis in
peritoneal dialysis: case report and a review of the literature. Nephrol Dial
Transplant. 1995;10:1240-1243.
Tanis BC, van der Pijl JW, van Ogtrop ML, Kibbelaar RE, Chang PC. Fatal fungal
peritonitis by Trichoderma longibrachiatum complicating peritoneal dialysis. Nephrol
Dial Transplant. 1995;10:114-116.
Tanis BC. Hypothalame- hypofysaire dysfunctie na bestraling van hersentumoren.
Ned Tijdschr v Geneesk. 1993;137:731.
Tanis BC, Vermorken JB, Bokkel Huinink WW, van Oosterom AT, Splinter TA,
Vendrik KJ, Sleijfer DT, van der Burg ME, van der Putten E, Pinedo HM. Multicenter
phase II study of spiroplatin. Oncology. 1992;49:99-103.
Tanis BC, Vermorken JB, Bokkel Huinink WW, Klein I, Gall H, van Oosterom AT,
Simonetti G, McVie JG, van der Vijgh WJ, Pinedo HM. Phase I study of spiroplatin.
Eur J Cancer. 1991;27:268-273.
Tanis BC, van Hooff MHA. Combinatie van carrière en gezin bij vrouwelijke artsen.
Ned Tijdschr v Geneesk. 1990;134:830.
Van Hooff MH, van de Loosdrecht AA, Tanis BC, Henselmans JM. Orale
anticonceptie en borstkanker bij jonge vrouwen. Ned Tijdschr v Geneesk. 1989;133:
2304-2305.
Groene Hart Ziekenhuis l Laatst afgedrukt op: 18-2-2014/3:06 PM
4/4

Download Report